Every recall we track for Pharmacy Innovations — 59 in all — plus the complaints and injury reports the public filed about them.
Pharmacy Innovations recalls sterile glycerin vials due to FDA finding insanitary conditions at their facility. These injectable vials may not be sterile and pose infection risks.
Pharmacy Innovations recalls 10ml vials of phosphatidylcholine/deoxycholic acid injectable due to FDA finding insanitary conditions at manufacturing facility.
Pharmacy Innovations recalls Dexamethasone injections due to FDA finding insanitary conditions at manufacturing facility. Products may cause infection if used.
Pharmacy Innovations recalls LidoCaine-PF 5% (5ml vial) injectable due to FDA finding insanitary conditions at manufacturing facility. This may cause infections if used.
Pharmacy Innovations recalls 5ml ethyl alcohol vials due to FDA-identified insanitary conditions. Products may not be sterile, posing infection risks. Consumers should contact the company for details.
Pharmacy Innovations recalls 10mg/0.25mg/ml injectable chlorpheniramine/hyoscyamine due to FDA finding of insanitary conditions at manufacturing facility. This product is for prescription use only.
Pharmacy Innovations recalls 5-Fluorouracil 1% and 2.5ML/5ML droptainers due to FDA finding of insanitary conditions at manufacturing facility. This poses a risk of contamination during eye treatment.
Pharmacy Innovations recalls magnesium chloride hexahydrate injectable due to FDA finding insanitary conditions at manufacturing facility. Products may not be sterile, posing infection risk.
Pharmacy Innovations recalls two glycerin/lidocaine/epinephrine vials due to FDA finding of insanitary conditions at manufacturing facility. These injectable products may not be sterile and could cause infections if used.
Pharmacy Innovations recalls Heparin/Lido HCl/Sodium Bicarbonate irrigation solution due to FDA findings of unsanitary conditions at the manufacturing facility. This product is prescription-only and may pose contamination risks.
Pharmacy Innovations recalls methotrexate intravitreal injections due to unsanitary facility conditions during production. This may lead to infections or other health risks if used.
Pharmacy Innovations recalls MITOMYCIN 0.2MG/ML Oph Solution products due to FDA finding insanitary conditions at manufacturing facility. Products may not be sterile, posing infection risks.
Pharmacy Innovations recalls 15ml glycerin injectables due to FDA finding unsanitary conditions at manufacturing facility. Products may contain harmful bacteria.
Pharmacy Innovations recalls EDETATE DISODIUM 1% OPH Solution (Rx Only) due to FDA finding insanitary conditions at manufacturing facility. This may pose a risk of contamination.
Pharmacy Innovations recalls Hydroxocobalamin 25MG/:2ML vials due to FDA-identified insanitary conditions causing potential contamination risks.
Pharmacy Innovations recalls two vitamin D3 injectable products due to FDA-identified unsanitary conditions at their manufacturing facility. This could lead to contamination risks for users.
Pharmacy Innovations recalls MITOMYCIN 0.4MG/ML OPH solutions due to FDA finding insanitary conditions at manufacturing facility. Products may not be sterile, posing infection risk.
Pharmacy Innovations recalls eye drops containing flurbiprofen-corn oil solution due to FDA findings of insanitary conditions at the manufacturing facility.
Pharmacy Innovations recalls Dutasteride 0.1% injectable vials due to FDA-identified insanitary conditions at manufacturing facility. No remedy specified in official notice.
Pharmacy Innovations recalls methylcobalamin injectable products due to FDA-identified insanitary conditions at manufacturing facility. Products may contain contaminants that could cause infection if used.
Pharmacy Innovations recalls LEVEMIR-STS 100U/ML vials due to FDA finding insanitary conditions at manufacturing facility. This poses a risk of contamination during injection.
Pharmacy Innovations recalls a specific injectable vitamin blend due to FDA finding unsanitary conditions at the manufacturing facility.
Pharmacy Innovations recalls 3ml albuterol inhalation solution due to FDA-identified insanitary conditions. Affected products may pose infection risks.
Pharmacy Innovations recalls polidocanol 50mg/ml (5%) 30ml vials due to FDA finding insanitary conditions. Stop using if you have this prescription drug.
Pharmacy Innovations recalls multiple prostaglandin E1 injection vials due to FDA finding insanitary conditions at manufacturing facility. Products may not be sterile, posing infection risks.
Pharmacy Innovations recalls hydroxocobalamin-PF 1mg/ml injectable due to FDA finding insanitary conditions at manufacturing facility. Consumers should contact pharmacy for details.
Pharmacy Innovations recalls 100mg/ml Progesterone-GS Oil Injectable due to FDA finding of insanitary conditions at manufacturing facility. This poses a risk of contamination.
Pharmacy Innovations recalls methylcobalamin injectables due to FDA finding of insanitary conditions at manufacturing facility. Products may not be sterile, posing infection risk.
Pharmacy Innovations recalls Cyclosporine (A) 0.1% to 2% products due to FDA finding insanitary conditions at manufacturing facility. Products may not be sterile, posing infection risks.
Pharmacy Innovations recalls semaglutide vials due to FDA finding of insanitary conditions at manufacturing facility. Products may contain contaminants that could cause infection.
Pharmacy Innovations recalls NADH 10mg/ml injectable (Rx only) due to FDA-identified insanitary conditions. This may pose sterility risks. Affected products were sold in Erie, PA.
Pharmacy Innovations recalls Clindam: FDA found unsanitary conditions at manufacturing facility. Products may be contaminated. Stop using immediately.
Pharmacy Innovations recalls Bupren: 0.9mg/ml injectable vials due to FDA finding insanitary conditions. Risk of contamination during manufacturing.
Pharmacy Innovations recalls 0.75% Minoxidil injectable vials due to FDA finding insanitary conditions at manufacturing facility. This poses a risk of contamination.
Pharmacy Innovations recalls 400mg/ml edetate calcium disodium vials due to FDA finding of insanitary conditions. This may cause infections if used.
Pharmacy Innovations recalls Vitamin D3 injectable due to FDA finding unsanitary conditions at manufacturing facility. No remedy specified in official notice.
Pharmacy Innovations recalls Ceftazidime Intravitreal vials due to insanitary conditions found during FDA inspection. This may lead to contamination risks for patients using the medication.
Pharmacy Innovations recalls multiple testosterone injection products due to FDA findings of insanitary conditions at manufacturing facility. Products may contain contaminants that could cause infection.
Pharmacy Innovations recalls Apom: 2mg/ml injectable vials due to FDA-identified insanitary conditions. No remedy specified in official notice.
Pharmacy Innovations recalls specific estradiol injectables due to FDA finding of insanitary conditions at manufacturing facility. Products may not be sterile, posing infection risks. Consumers should contact pharmacy for details.
Pharmacy Innovations recalls VORICONAZOLE 10MG/ML (10ML DROPPER) OPH SOLUTION due to FDA finding insanitary conditions at the facility. This medication is prescription-only and may pose infection risks.
Pharmacy Innovations recalls Estradiol 0.05% OPH Solution (Rx Only) due to FDA finding insanitary conditions at manufacturing facility. This may pose a risk of contamination.
Pharmacy Innovations recalls 0.2% polyhexamidine ophthalmic solution due to FDA finding of insanitary conditions at manufacturing facility. This may pose a risk of contamination.
Pharmacy Innovations recalls BSS Plus/Lid:1% injectable syringes due to FDA finding of insanitary conditions. Products may not be sterile, risking infection.
Pharmacy Innovations recalls specific injectable medication vials due to FDA finding of insanitary conditions at manufacturing facility. These vials may not be sterile and pose infection risks.
Pharmacy Innovations recalls SCOPOLAMINE HYDROBROMIDE 0.25% OPH SOLUTION (Rx Only) due to FDA finding insanitary conditions at the manufacturing facility. Consumers should check product details and contact the company for guidance.
Pharmacy Innovations recalls specific PAPAVERINE/PHENTOLAMINE injectable vials due to FDA finding of insanitary conditions at manufacturing facility. No remedy specified in recall notice.
Pharmacy Innovations recalls multiple vitamin injectable products manufactured at a facility with insanitary conditions. The FDA found lack of sterility assurance, posing potential infection risks. Consumers should contact the company for details.
Pharmacy Innovations recalls GENTAMICIN BLADDER irrigation products due to FDA finding insanitary conditions at manufacturing facility. Products may not be sterile, risking infection.
Pharmacy Innovations recalls 10% phenol injectable vials due to FDA finding insanitary conditions at manufacturing facility. This poses a risk of contamination. Consumers should contact the company for details.
Pharmacy Innovations recalls several ophthalmic tacrolimus solutions produced between October 2022 due to insanitary conditions at the facility, posing a sterility risk. Consumers should contact the company for details.
Pharmacy Innovations recalls multiple injectable medicine vials due to FDA finding insanitary conditions at manufacturing facility. Products contain PE1/PAPAV/PHEN and PHENT compounds at various concentrations. No remedy specified in recall notice.
Pharmacy Innovations recalls Acetylcysteine 10% Ophthalmic Solution due to FDA finding insanitary conditions at manufacturing facility. This may cause infections if used.
Pharmacy Innovations recalls TOBRAMYCIN FORTIFIED 15MG/ML OPH SOLUTION due to FDA finding insanitary conditions at manufacturing facility. This eye drop product is for prescription use only.
Pharmacy Innovations recalls two atropine sulfate droppers due to FDA finding insanitary conditions at their facility. Products may not be sterile, posing infection risks.
Pharmacy Innovations recalls specific vitamin injectable products due to FDA-identified unsanitary facility conditions. Consumers should check product labels for the listed formulations and contact the company for details.
Pharmacy Innovations recalls glutathione L reduced inhalation and injectable products due to FDA-identified insanitary conditions at manufacturing facility. Products may contain contaminants that could cause infection.
